FDA’s Expedited Programs and Their Impact on the Availability of New Therapies von Damle, Nehar, Shah, Shilvi, Nagraj, Praneeta, Tabrizi, Pardis, Rodriguez, Gustavo Enrique, Bhambri, Rahul

Volltext